Emmanuel Thomas, M.D., Ph.D.
- Research Associate Professor
- Medical Protocol Review and Monitoring Committee (MPRMC)-Member GI SDG-Member Cancer Control Research Program-Member
- Microbiology and Immunology
Dr. Thomas' area of expertise is on Hepatitis B/C and hepatocellular carcinoma (HCC). Dr. Thomas has an active viral hepatitis screening program, and he is developing advanced models to study hepatocarcinogenesis. His integrated, multidisciplinary program is funded by the NIH through an NIGMS five-year, renewable Outstanding Investigator Award (R35) on chronic viral infections. In addition, he has a five-year Bankhead-Coley Clinical Cancer Research Grant for the early identification of patients with liver disease most at risk to develop HCC.